LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-79 Cr | ₹-57 Cr | ₹-37 Cr | ₹-78 Cr | ₹-64 Cr |
What is the latest Cash Flow from Investing Activities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-79 Cr |
| Mar2024 | ₹-57 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-78 Cr |
| Mar2021 | ₹-64 Cr |
How is Cash Flow from Investing Activities of LINCOLN PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-79 Cr | Negative | |
| Mar2024 | ₹-57 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-78 Cr | Negative | |
| Mar2021 | ₹-64 Cr | - | |
Compare Cash Flow from Investing Activities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,215.7 Cr | -2.1% | -3.4% | 9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -2.1% |
-3.4% |
9.9% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses